Clinical trial
A Multi-center, Random, Double Blind and Placebo Control Phase III Clinical Study on the Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
NCT03804229 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Random, Double Blind and Placebo Control Phase III Clinical Study on the Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
- Lead sponsor
- Capital Medical University
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- October 29, 2019
- Completion date
- June 7, 2026
- Enrollment
- 707 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vascular dementia